
Imaging 2020 VII:
Bridging Molecular Imaging and Therapy
September 18-22, 2011
In 2011, we will explore new links between molecular imaging and therapy. Imaging - especially molecular imaging - will play a critical role in the creation, monitoring and control of new, highly potent interventions. With new therapeutic technologies such as RNA interference, nanotherapeutics and stem cells entering the clinic, molecular imaging is increasingly required for design, optimization and validation. Discussions will address advances in imaging modalities from MRI to PET, optical and ultrasound imaging, fundamental advances in important therapies and the future role of chemistry in imaging.
Key to meeting the challenges inherent in a complex future is open and effective communication among basic and clinical researchers from a wide spectrum of relevant disciplines. The goal of Imaging in 2020 is to catalyze this communication by laying the technical foundation for it, and by providing a format that is intentionally less structured than the traditional scientific meeting, allowing for extensive, meaningful interactions in a casual, comfortable environment. We hope to foster the development of enduring associations that will lead to innovative solutions and applications.
Imaging in 2020 VII will be held at the Jackson Lake Lodge in Jackson Hole, Wyoming. This beautiful location in Grand Teton National Forest is easily accessible from Jackson Airport. Breathtaking views of the Grand Tetons provide a colorful backdrop to the meeting. Participants will have the opportunity during the unscheduled afternoons to enjoy a variety of outdoor activities, such as hiking, fishing, boating, horseback riding, or just relaxing in a truly spectacular natural setting.

home